Cyrus Selects CYR212 as Candidate for IgG-Driven Autoimmune Diseases Cyrus Biotechnology, an AI-driven therapeutics company, announced the selection of CYR212 as its clinical development candidate for chronic IgG-driven autoimmune diseases.…
GeneDx Advances Genomics Research, Impacting Over 22,000 Patients GeneDx (Nasdaq: WGS), a pioneer in genomic insights for improved health outcomes, continues to make significant strides in advancing scientific research, especially…
Approval of Merck’s GARDASIL® Expanded for Males in China Merck (NYSE: MRK), known as MSD outside the United States and Canada, has announced that the National Medical Products Administration (NMPA)…
QIAGEN Backs UK Initiative to Sequence 100,000 Newborn Genomes QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) has announced a strategic partnership with Genomics England to support the ambitious Generation Study,…
Wearable Data Integrated into EHR for Personalized Care by Validic At CES, Validic, a leader in digital health and personalized care technology, unveiled a new integration of physical activity data…
Collaboration Between Team Gleason and Synchron Expands BCI Efforts Synchron, a leading brain-computer interface (BCI) company, and Team Gleason, a foundation focused on enhancing the lives of individuals living with…
Conference Preview: Avenacy Updates 2025 Strategy Ahead of J.P. Morgan Healthcare Event Avenacy, a specialty pharmaceutical company focused on providing critical injectable medications, has shared updates regarding its recent business…
Foot & Ankle: Fusion Orthopedics Strategically Expands Reach Fusion Orthopedics USA, LLC (“Fusion”) has announced the successful expansion of its product portfolio with the acquisition of Metalogix External Fixation Systems.…
Certification Achieved by ModMed for AI-Powered Scribe by ASTP/ONC ModMed®, a leading innovator in healthcare technology, announced that its electronic health records (EHR) platform, EMA®, has successfully achieved certification from…
Merz Group Unveils New OTC Business Player for the New Year At the turn of the year, Merz Lifecare and WindStar Medical completed their merger, resulting in the formation of…
Invests $150M in Patho Care via PathoCare Holdings, Hamershlag Private Capital Hamershlag Private Capital Management Limited (HPCM), a prominent health technology investment firm, invests in Patho Care, LLC, a leading…
Analgesic from Xgene Pharmaceutical Reduces Pain and Opioid Use in Post-Surgical Trial Xgene Pharmaceutical has revealed further findings from a positive, multi-center, placebo-controlled, dose-ranging Phase 2b study (registration number: NCT06017999)…